• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Pfizer Inc.

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Pfizer Invites Public to View and Listen to Webcast of January 30 Conference Call with Analysts
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Declares First-Quarter 2024 Dividend
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Completes Acquisition of Seagen
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Provides Full-Year 2024 Guidance
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    FDA and EMA Accept Marstacimab Regulatory Submissions for the Treatment of Hemophilia A and B
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Marstacimab Phase 3 Data Presented at ASH 2023 Demonstrate Significant Bleed Reduction in Hemophilia A and B
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    European Commission Approves Pfizer’s ELREXFIO® for Relapsed and Refractory Multiple Myeloma
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Announces Topline Phase 2b Results of Oral GLP-1R Agonist, Danuglipron, in Adults with Obesity
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual Meeting
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Reports Third-Quarter 2023 Results
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
    From Pfizer Inc.
    Via Business Wire
    Tickers BNTX PFE
    FDA Approves PENBRAYA™, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    U.S. FDA Approves Pfizer’s VELSIPITY™ for Adults with Moderately to Severely Active Ulcerative Colitis (UC)
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Declares Fourth-Quarter 2023 Dividend
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Broadens Portfolio of Respiratory Vaccines Recommended by CDC Advisory Committee with ABRYSVO™ for RSV
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    European Commission Approves Pfizer’s LITFULO™ for Adolescents and Adults With Severe Alopecia Areata
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
    From Pfizer Inc.
    Via Business Wire
    Tickers BNTX PFE
    Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
    From Pfizer Inc.
    Via Business Wire
    Tickers BNTX PFE
    Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences
    From Pfizer Inc.
    Via Business Wire
    Tickers PFE
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.